Evaluating the safety profile of defibrotide in sickle cell disease: an <i>in vitro</i> study by Laura Bencheikh, Meghan Perkins, Kim Anh Nguyen, Clara Noizat, Anoosha Habibi, Marie Cambot, Pablo Bartolucci

Get full text

THromboprophylaxis In Sickle Cell Disease with central venous catheters (THIS): an internal pilot randomised controlled trial protocol by George Tomlinson, Ziad Solh, Jameel Abdulrehman, Kevin H M Kuo, Stephanie Forté, Lauren Bolster, Haowei (Linda) Sun, Pablo Bartolucci

Get full text

Key role of long-duration cardiac rhythm monitoring in patients with sickle cell disease with atrial hyperexcitability by Thuy Linh Dang, Thibaut Moulin, Gonzalo de Luna, Sihem Iles, Anaïs Lamadieu, David Calvet, Geneviève Derumeaux, Pablo Bartolucci, Nicolas Lellouche, Thomas d’Humières

Get full text

Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome. by Keyvan Razazi, Enora Berti, Jerome Cecchini, Guillaume Carteaux, Anoosha Habibi, Pablo Bartolucci, Romain Arrestier, Ségolène Gendreau, Nicolas de Prost, Anne Hulin, Armand Mekontso Dessap

Get full text

Podocyte dysfunction driven by heme in sickle-cell nephropathy by Chloé Ben Ali, Antoine Morel, Marion Morvan, Anissa Moktefi, Kim-Anh Nguyen-Peyre, Margaux Van Wynsberghe, Hamza Sakhi, Pablo Bartolucci, Vincent Audard, Carole Hénique

Get full text